Yokohama, Japan

Amranul Haque

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Somar Corporation, Other. Active years: 2017.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 216 
 
Somar Corporation
 patents
silverMedal1 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amranul Haque: Innovator in Cell Culture Technology

Introduction

Amranul Haque is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of cell culture technology, particularly in the area of pluripotent stem cells. His innovative work has the potential to advance research and applications in regenerative medicine.

Latest Patents

Amranul Haque holds a patent for a cell culture substrate and a method for inducing differentiation of pluripotent stem cells using this substrate. The patent addresses the need for a reliable cell culture substrate that allows for the culturing of pluripotent stem cells and their differentiation into specific cell types, especially neural and neural progenitor cells, with high purity. The solution involves immobilizing or coating the substrate's surface with one or more components selected from N-cadherin or related fusion proteins.

Career Highlights

Throughout his career, Amranul Haque has worked with various organizations, including Somar Corporation. His expertise in cell culture technology has positioned him as a valuable contributor to advancements in the field.

Collaborations

Amranul has collaborated with esteemed colleagues such as Toshihiro Akaike and Masato Nagaoka. These partnerships have further enriched his research and development efforts.

Conclusion

Amranul Haque's innovative contributions to cell culture technology highlight his role as a key inventor in the field. His work not only addresses critical challenges in stem cell research but also paves the way for future advancements in regenerative medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…